Annual Short Term Debt
$2.72 M
+$207.00 K+8.25%
31 December 2023
Summary:
Rocket Pharmaceuticals annual short term debt is currently $2.72 million, with the most recent change of +$207.00 thousand (+8.25%) on 31 December 2023. During the last 3 years, it has risen by +$164.00 thousand (+6.43%). RCKT annual short term debt is now -61.99% below its all-time high of $7.14 million, reached on 31 December 2020.RCKT Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.85 M
-$12.00 K-0.42%
30 September 2024
Summary:
Rocket Pharmaceuticals quarterly short term debt is currently $2.85 million, with the most recent change of -$12.00 thousand (-0.42%) on 30 September 2024. Over the past year, it has increased by +$131.00 thousand (+4.82%). RCKT quarterly short term debt is now -62.34% below its all-time high of $7.56 million, reached on 30 June 2021.RCKT Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCKT Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +4.8% |
| 3 y3 years | +6.4% | +11.6% |
| 5 y5 years | +183.8% | +197.5% |
RCKT Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +8.3% | -4.9% | +20.7% |
| 5 y | 5 years | -62.0% | +183.8% | -62.3% | +197.5% |
| alltime | all time | -62.0% | -62.3% |
Rocket Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.85 M(-0.4%) |
| June 2024 | - | $2.86 M(-0.5%) |
| Mar 2024 | - | $2.87 M(+5.7%) |
| Dec 2023 | $2.72 M(+8.3%) | $2.72 M(-4.8%) |
| Sept 2023 | - | $2.85 M(-4.7%) |
| June 2023 | - | $2.99 M(+15.2%) |
| Mar 2023 | - | $2.60 M(+3.5%) |
| Dec 2022 | $2.51 M(-1.7%) | $2.51 M(+6.4%) |
| Sept 2022 | - | $2.36 M(-3.7%) |
| June 2022 | - | $2.45 M(-3.5%) |
| Mar 2022 | - | $2.54 M(-0.5%) |
| Dec 2021 | $2.55 M | $2.55 M(+2.9%) |
| Sept 2021 | - | $2.48 M(-67.2%) |
| June 2021 | - | $7.56 M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $7.32 M(+2.5%) |
| Dec 2020 | $7.14 M(+646.6%) | $7.14 M(+0.3%) |
| Sept 2020 | - | $7.13 M(+192.0%) |
| June 2020 | - | $2.44 M(+6.3%) |
| Mar 2020 | - | $2.29 M(+139.8%) |
| Dec 2019 | $957.00 K(>+9900.0%) | $957.00 K(+2.4%) |
| Sept 2019 | - | $935.00 K(+2.4%) |
| June 2019 | - | $913.00 K(+2.4%) |
| Mar 2019 | - | $892.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2014 | $4.60 M(+226.5%) | $4.60 M(+54.5%) |
| Sept 2014 | - | $2.98 M(+111.3%) |
| Dec 2013 | $1.41 M(-48.0%) | $1.41 M |
| Dec 2012 | $2.71 M | - |
FAQ
- What is Rocket Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly short term debt year-on-year change?
What is Rocket Pharmaceuticals annual short term debt?
The current annual short term debt of RCKT is $2.72 M
What is the all time high annual short term debt for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual short term debt is $7.14 M
What is Rocket Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of RCKT is $2.85 M
What is the all time high quarterly short term debt for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly short term debt is $7.56 M
What is Rocket Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, RCKT quarterly short term debt has changed by +$131.00 K (+4.82%)